Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy

Chemico-Biological Interactions

Volumn 219, Issue , 2014, Pages 64-75

  Ahad, Amjid ^a   Ganai, Ajaz Ahmad ^a   Mujeeb, Mohd ^a   Siddiqui, Waseem Ahmad ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Ellagic acid; High fat diet; Inflammation; Renal function

Indexed keywords

ELLAGIC ACID; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; DRUG EFFECT; KIDNEY CELL CULTURE; KIDNEY TUBULE CELL; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

EID: 84902166470     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.05.011     Document Type: Article

References (65)

1. E. Ritz, X.X. Zeng, and I. Rychlik Clinical manifestation and natural history of diabetic nephropathy Contrib. Nephrol. 170 2011 19 27
2. A.T. Reutens, and R.C. Atkins Epidemiology of diabetic nephropathy Contrib. Nephrol. 170 2011 1 7
3. P. Balakumar, M.K. Arora, S.S. Ganti, J. Reddy, and M. Singh Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions Pharmacol. Res. 60 2009 24 32
4. J.F. Navarro-Gonzalez, C. Mora-Fernandez, M. Muros de Fuentes, and J. Garcia-Perez Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy Nat. Rev. Nephrol. 7 2011 327 340
5. A. Kuhad, and K. Chopra Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway Life Sci. 84 2009 296 301
6. F.T. Lee, Z. Cao, D.M. Long, S. Panagiotopoulos, G. Jerums, M.E. Cooper, and J.M. Forbes Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy J. Am. Soc. Nephrol. 15 2004 2139 2151 (Pubitemid 39031352)
7. H. Ha, M.R. Yu, Y.J. Choi, M. Kitamura, and H.B. Lee Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells J. Am. Soc. Nephrol. 13 2002 894 902 (Pubitemid 34274085)
8. G. Gruden, G. Setti, A. Hayward, D. Sugden, S. Duggan, D. Burt, R.E. Buckingham, L. Gnudi, and G. Viberti Mechanical stretch induces monocyte chemoattractant activity via an NF-kappaB-dependent monocyte chemoattractant protein-1-mediated pathway in human mesangial cells: inhibition by rosiglitazone J. Am. Soc. Nephrol. 16 2005 688 696 (Pubitemid 41725105)
9. J. Wada, and H. Makino Inflammation and the pathogenesis of diabetic nephropathy Clin. Sci. (Lond.) 124 2013 139 152
10. M. Karin, and F.R. Greten NF-kappaB: linking inflammation and immunity to cancer development and progression Nat. Rev. Immunol. 5 2005 749 759 (Pubitemid 41400849)
11. V. Lopez-Parra, B. Mallavia, J. Egido, and C. Gomez-Guerrero Immunoinflammation in diabetic nephropathy: molecular mechanisms and therapeutic options D.J. Chan, Diabetic Nephropathy 2012 InTech Croatia, Europe
12. G. Frangioudakis, and G.J. Cooney Acute elevation of circulating fatty acids impairs downstream insulin signalling in rat skeletal muscle in vivo independent of effects on stress signalling J. Endocrinol. 197 2008 277 285 (Pubitemid 351696240)
13. Y.L. Marchand-Brustel, P. Gual, T. Gremeaux, T. Gonzalez, R. Barres, and J. Tanti Fatty acid-induced insulin resistance. role of insulin receptor substrate 1 serine phosphorylation in the retroregulation of insulin signalling Biochem. Soc. Trans. 31 2003 1152 1156 (Pubitemid 38030928)
14. S. Ohga, K. Shikata, K. Yozai, S. Okada, D. Ogawa, H. Usui, J. Wada, Y. Shikata, and H. Makino Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation Am. J. Physiol. Renal Physiol. 292 2007 F1141 F1150
15. W.C. Lee, H.C. Chen, C.Y. Wang, P.Y. Lin, T.T. Ou, C.C. Chen, M.C. Wen, J. Wang, and H.J. Lee Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-Beta and NF-kappaB Biosci. Biotechnol. Biochem. 74 2010 1355 1361
16. Z. Zhang, W. Yuan, L. Sun, F.L. Szeto, K.E. Wong, X. Li, J. Kong, and Y.C. Li 1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells Kidney Int. 72 2007 193 201 (Pubitemid 47067389)
17. V. Soetikno, F. Sari, P. Veeraveedu, R. Thandavarayan, M. Harima, V. Sukumaran, A. Lakshmanan, K. Suzuki, H. Kawachi, and K. Watanabe Curcumin ameliorates macrophage infiltration by inhibiting NF-kappaB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy Nutr. Metab. 8 2011 35
18. S.K. Panchal, L. Ward, and L. Brown Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats Eur. J. Nutr. 52 2013 559 568
19. Palanisamy Malini, Ganesan Kanchana, and M. Rajadurai Antidiabetic efficacy of ellagic acid in streptozotocin induced diabetes mellitus in albino wistar rats Asian J. Pharm. Clin. Res. 4 2011 124 128
20. C.Y. Chao, M.C. Mong, K.C. Chan, and M.C. Yin Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice Mol. Nutr. Food Res. 54 2010 388 395
21. L.S. Adams, N.P. Seeram, B.B. Aggarwal, Y. Takada, D. Sand, and D. Heber Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells J. Agric. Food Chem. 54 2006 980 985 (Pubitemid 43274141)
22. M.U. Rehman, M. Tahir, F. Ali, W. Qamar, A. Lateef, R. Khan, A. Quaiyoom, O.H. Oday, and S. Sultana Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice. the protective effect of ellagic acid Mol. Cell Biochem. 365 2012 119 127
23. S. Corbett, J. Daniel, R. Drayton, M. Field, R. Steinhardt, and N. Garrett Evaluation of the anti-inflammatory effects of ellagic acid J. Perianesth. Nurs. 25 2010 214 220
24. N. Al-Kharusi, H.A. Babiker, S. Al-Salam, M.I. Waly, A. Nemmar, I. Al-Lawati, J. Yasin, S. Beegam, and B.H. Ali Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: a dose-dependent study Eur. Rev. Med. Pharmacol. Sci. 17 2013 299 310
25. A. Atessahin, A.O. Ceribasi, A. Yuce, O. Bulmus, and G. Cikim Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats Basic Clin. Pharmacol. Toxicol. 100 2007 121 126 (Pubitemid 46146716)
26. P. Anitha, R.V. Priyadarsini, K. Kavitha, P. Thiyagarajan, and S. Nagini Ellagic acid coordinately attenuates Wnt/beta-catenin and NF-kappaB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis Eur. J. Nutr. 52 2013 75 84
27. B.B. Aggarwal, and S. Shishodia Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning Ann. N. Y. Acad. Sci. 1030 2004 434 441 (Pubitemid 40378943)
28. M. Edderkaoui, I. Odinokova, I. Ohno, I. Gukovsky, V.L. Go, S.J. Pandol, and A.S. Gukovskaya Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells World J. Gastroenterol. 14 2008 3672 3680
29. OECD, Repeated dose 28 day oral toxicity study in rodents. OECD Guideline 407 for the Testing of Chemicals, Organization for Economic Cooperation and Development, Paris, 1995.
30. C. Ghai A Text Book of Practical Physiology 1990 Jaypee Brothers (P) Ltd. India
31. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
32. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358 (Pubitemid 9194347)
33. R.S. Danda, N.M. Habiba, H. Rincon-Choles, B.K. Bhandari, J.L. Barnes, H.E. Abboud, and P.E. Pergola Kidney involvement in a nongenetic rat model of type 2 diabetes Kidney Int. 68 2005 2562 2571 (Pubitemid 43251001)
34. JBDSICG, The Management of Diabetic Ketoacidosis in Adults, NHS Diabetes, Joint British Diabetes Societies Inpatient Care Group, 2010.
35. A.C. Powers Diabetes Mellitus 16 ed. 2005 McGraw-Hill New York
36. L. Arreola-Mendoza, J.L. Reyes, E. Melendez, D. Martin, M.C. Namorado, E. Sanchez, and L.M. Del Razo Alpha-tocopherol protects against the renal damage caused by potassium dichromate Toxicology 218 2006 237 246 (Pubitemid 41821354)
37. D.J. Jollow, J.R. Mitchell, N. Zampaglione, and J.R. Gillette Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite Pharmacology 11 1974 151 169
38. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63 (Pubitemid 14203433)
39. S. Siddiqui, H. Ahsan, M.R. Khan, and W.A. Siddiqui Protective effects of tocotrienols against lipid-induced nephropathy in experimental type-2 diabetic rats by modulation in TGF-β expression Toxicol. Appl. Pharmacol. 273 2013 314 324
40. S. Ahmed, A. Rahman, M. Saleem, M. Athar, and S. Sultana Ellagic acid ameliorates nickel induced biochemical alterations: diminution of oxidative stress Hum. Exp. Toxicol. 18 1999 691 698 (Pubitemid 30032178)
41. P. Attilio, C. Merritt, J. Sims, N. Kane, and J. O'Sullivan The effect of ellagic acid on platelet activation as measured by the quantification of P-selectin using flow cytometry AANA J. 78 2010 453 459
42. A. Berni, M.R. Grossi, G. Pepe, S. Filippi, S. Muthukumar, C. Papeschi, A.T. Natarajan, and F. Palitti Protective effect of ellagic acid (EA) on micronucleus formation induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in mammalian cells, in in vitro assays and in vivo Mutat. Res. 746 2012 60 65
43. A. Biswas, S. Chatterjee, R. Chowdhury, S. Sen, D. Sarkar, M. Chatterjee, and J. Das Antidiabetic effect of seeds of Strychnos potatorum Linn. in a streptozotocin-induced model of diabetes Acta Pol. Pharm. 69 2012 939 943
44. T.D. Gilmore Introduction to NF-kappaB: players, pathways, perspectives Oncogene 25 2006 6680 6684 (Pubitemid 44657845)
45. J.E. Kim, M.H. Lee, D.H. Nam, H.K. Song, Y.S. Kang, J.E. Lee, H.W. Kim, J.J. Cha, Y.Y. Hyun, S.Y. Han, K.H. Han, J.Y. Han, and D.R. Cha Celastrol, an NF-kappaB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice PLoS One 8 2013 e62068
46. A.W. Ferrante Jr. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation J. Intern. Med 262 2007 408 414 (Pubitemid 47404372)
47. R.G. Baker, M.S. Hayden, and S. Ghosh NF-kappaB, inflammation, and metabolic disease Cell Metab. 13 2011 11 22
48. M.Y. Donath, and S.E. Shoelson Type 2 diabetes as an inflammatory disease Nat. Rev. Immunol. 11 2011 98 107
49. S. PintoMda, J.E. de Carvalho, F.M. Lajolo, M.I. Genovese, and K. Shetty Evaluation of antiproliferative, anti-type 2 diabetes, and antihypertension potentials of ellagitannins from strawberries (Fragaria × ananassa Duch.) using in vitro models J. Med. Food 13 2010 1027 1035
50. P. Muthenna, C. Akileshwari, and G.B. Reddy Ellagic acid, a new antiglycating agent: its inhibition of N-(carboxymethyl)lysine Biochem. J. 442 2012 221 230
51. A.E. Kitabchi, G.E. Umpierrez, J.M. Miles, and J.N. Fisher Hyperglycemic crises in adult patients with diabetes Diabetes Care 32 2009 1335 1343
52. D. Cornelio Favarin, M. Martins Teixeira, E. Lemos de Andrade, C. de Freitas Alves, J.E. Lazo Chica, C. Arterio Sorgi, L.H. Faccioli, and A. Paula Rogerio Anti-inflammatory effects of ellagic acid on acute lung injury induced by acid in mice Mediators Inflamm. 2013 2013 164202
53. A. Gonzalez-Sarrias, M. Larrosa, F.A. Tomas-Barberan, P. Dolara, and J.C. Espin NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts Br. J. Nutr. 104 2010 503 512
54. C. Gomez-Guerrero, B. Mallavia, and J. Egido Targeting inflammation in cardiovascular diseases. Still a neglected field? Cardiovasc. Ther. 30 2012 e189 e197
55. B. Yang, A. Hodgkinson, P.J. Oates, B.A. Millward, and A.G. Demaine High glucose induction of DNA-binding activity of the transcription factor NFκB in patients with diabetic nephropathy Biochim. Biophys. Acta 1782 2008 295 302
56. J.S. Nam, M.H. Cho, G.T. Lee, J.S. Park, C.W. Ahn, B.S. Cha, S.K. Lim, K.R. Kim, H.J. Ha, and H.C. Lee The activation of NF-κB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy Diabetes Res. Clin. Pract. 81 2008 25 32
57. Q. Jiang, P. Liu, X. Wu, W. Liu, X. Shen, T. Lan, S. Xu, J. Peng, X. Xie, and H. Huang Berberine attenuates lipopolysaccharide-induced extracellular matrix accumulation and inflammation in rat mesangial cells: involvement of NF-kappaB signaling pathway Mol. Cell Endocrinol. 331 2011 34 40
58. S. Mezzano, C. Aros, A. Droguett, M.E. Burgos, L. Ardiles, C. Flores, H. Schneider, M. Ruiz-Ortega, and J. Egido NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy Nephrol. Dial. Transplant. 19 2004 2505 2512 (Pubitemid 39360096)
59. A. Riad, J. Du, S. Stiehl, D. Westermann, Z. Mohr, M. Sobirey, W. Doehner, V. Adams, M. Pauschinger, H.P. Schultheiss, and C. Tschope Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus Eur. J. Pharmacol. 569 2007 204 211 (Pubitemid 47202015)
60. I.S. Park, H. Kiyomoto, S.L. Abboud, and H.E. Abboud Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes Diabetes 46 1997 473 480 (Pubitemid 27090278)
61. A.A. Elmarakby, and J.C. Sullivan Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy Cardiovasc. Ther. 30 2012 49 59
62. J.C. Tharappel, H.J. Lehmler, C. Srinivasan, L.W. Robertson, B.T. Spear, and H.P. Glauert Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3′,4,4′-tetrachlorobiphenyl (PCB-77) Food Chem. Toxicol. 46 2008 3467 3474
63. B. Gauliard, D. Grieve, R. Wilson, A. Crozier, C. Jenkins, W.D. Mullen, and M. Lean The effects of dietary phenolic compounds on cytokine and antioxidant production by A549 cells J. Med. Food 11 2008 382 384 (Pubitemid 351948179)
64. P. Lesca Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice Carcinogenesis 4 1983 1651 1653 (Pubitemid 14206932)
65. W.J. Lee, H.C. Ou, W.C. Hsu, M.M. Chou, J.J. Tseng, S.L. Hsu, K.L. Tsai, and W.H. Sheu Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells J. Vasc. Surg. 52 2010 1290 1300